BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Ischemia
,
Embryo
,
Anticancer prodrugs
,
Vitamin E
,
rs7903146
,
DNMT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neoplasms experimental
Summary
General Info
Curated Studies
Most Correlated Studies
Study of Multiple Solid Cancers
Bone marrow of mice with prostate cancer cell line xenografts
Squamous cell cervical carcinoma CaSki cells with siRNA-mediated ER-a36 gene knockdown
Pancreatic ductal adenocarcinomas and liver and peritoneal metastases
Gene expression of adrenocortical tumors - adrenocortical carcinomas and adenomas
Explore Curated Studies Results
Literature
Most Relevant Literature
Editorial: spine metastasis.
Single-agent combinatorial cancer therapy.
Review: Fluorescent protein-based tumor models.
Synthesis and cytotoxicity of chalcones and 5-deoxyflavonoids.
Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen g…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms
Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms
Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ